Skip to main content
Premium Trial:

Request an Annual Quote

Seer: Meeta Gulyani

Meeta Gulyani has been appointed to the board of directors of Seer. She is the executive VP and head of strategy, business development, and transformation for the life science business of Merck KGaA in Germany, which operates as MilliporeSigma in the US and Canada. Previously, she was executive VP and head of strategy and global franchises for the biopharma business of Merck KGaA, and before that, general manager for Roche South Asia as well as VP and head of global portfolio management at Roche. Gulyani holds an MBA from the Asian Institute of Management in the Philippines and a bachelor's degree in economics from the Shri Ram College of Commerce at Delhi University in India.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.